&nbsp;

OH-Indigenous-cancer-strategy_EN.pdf

New

Dec 2025

Document

OH-Indigenous-cancer-strategy_FR.pdf

New

Dec 2025

Document

OH-Indigenous-cancer-strategy-executive-summary_EN.pdf

New

Dec 2025

Document

OH-Indigenous-cancer-strategy-executive-summary_FR.pdf

New

Dec 2025

Regimen

OXALRALT+BEVA

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Funding:

New Drug Funding Program

Bevacizumab (Biosimilar) - Metastatic Colorectal, Small Bowel, or Appendiceal Cancer

New Drug Funding Program

Raltitrexed - Metastatic Colorectal Small Bowel or Appendiceal Cancer

, Collapse Show fewer tags

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2025

Programme ontarien de dépistage du cancer du poumon

Programme ontarien de dépistage du cancer du poumon : questions fréquemment posées aux fournisseurs de soins de santé

Drug

PANitumumab

Other Name(s): Vectibix®

Quick Link(s): Drug Monograph, Patient Info Sheet

Jan 2025

Regimen

PNAT

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

ponatinib - For the treatment of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia, according to specific clinical criteria

, Collapse Show fewer tags

Drugs Used:

ponatinib

... Show more tags

Quick Link(s):

Regimen Monograph

Dec 2025

Regimen

PNAT

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative, Palliative

Funding:

Exceptional Access Program

ponatinib - For the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), according to specific clinical criteria